Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
暂无分享，去创建一个
E. Bergstralh | M. Blute | H. Zincke | J. Slezak | S. Sweat
[1] P. Nelson,et al. Determining cause of death in prostate cancer: are death certificates valid? , 2001, Journal of the National Cancer Institute.
[2] E. Bergstralh,et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management , 2001, Cancer.
[3] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[4] J. Hanley,et al. Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .
[5] P. Schellhammer,et al. Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.
[6] M. Blute,et al. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. , 1995, The Journal of urology.
[7] M. Blute,et al. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. , 1991, The Journal of urology.
[8] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[9] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.